0001731122-24-000268.txt : 20240216
0001731122-24-000268.hdr.sgml : 20240216
20240216094403
ACCESSION NUMBER: 0001731122-24-000268
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240213
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Binette Francois
CENTRAL INDEX KEY: 0001940686
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38758
FILM NUMBER: 24646045
MAIL ADDRESS:
STREET 1: 2022 N. ALVARADO STREET
CITY: LOS ANGELES
STATE: CA
ZIP: 90039
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RENOVARO INC.
CENTRAL INDEX KEY: 0001527728
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 452259340
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: CENTURY CITY MEDICAL PLAZA
STREET 2: 2080 CENTURY CITY EAST
CITY: SUITE 906 LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 45 39179840
MAIL ADDRESS:
STREET 1: CENTURY CITY MEDICAL PLAZA
STREET 2: 2080 CENTURY CITY EAST
CITY: SUITE 906 LOS ANGELES
STATE: CA
ZIP: 90067
FORMER COMPANY:
FORMER CONFORMED NAME: RENOVARO BIOSCIENCES INC.
DATE OF NAME CHANGE: 20230807
FORMER COMPANY:
FORMER CONFORMED NAME: Enochian Biosciences Inc.
DATE OF NAME CHANGE: 20230804
FORMER COMPANY:
FORMER CONFORMED NAME: Renovaro Biosciences Inc.
DATE OF NAME CHANGE: 20230802
4
1
ownership.xml
X0508
4
2024-02-13
0
0001527728
RENOVARO INC.
RENB
0001940686
Binette Francois
C/O RENOVARO BIOSCIENCES INC.
9480 NE 2ND AVENUE #73
MIAMI
FL
33138
0
1
0
0
COO and Executive VP for R&D
0
Option to Purchase Common Stock
2.38
2024-02-13
4
D
0
65000
D
2032-07-22
Common Stock
65000
0
D
Option to Purchase Common Stock
1.92
2024-02-13
4
A
0
65000
A
2024-02-13
2032-07-22
Common Stock
65000
65000
D
Option to Purchase Common Stock
8.40
2024-02-13
4
D
0
65000
D
2023-04-18
2032-02-22
Common Stock
65000
0
D
Option to Purchase Common Stock
1.92
2024-02-13
4
A
0
65000
A
2024-02-13
2032-02-22
Common Stock
65000
65000
D
Option to Purchase Common Stock
2.15
2024-02-13
4
D
0
40000
D
2032-10-18
Common Stock
40000
0
D
Option to Purchase Common Stock
1.92
2024-02-13
4
A
0
40000
A
2032-10-18
Common Stock
40000
40000
D
60% of the option vested on January 22, 2023 and 40% on July 22, 2023.
The transactions reported herein reflect a stock option repricing (the "Option Repricing") effective on February 13, 2024 (the "Repricing Date"). Pursuant to the Option Repricing, which was approved by stockholders on January 25, 2024, the exercise price of all repriced options has been amended to $1.92 per share, the closing price of the Company's common stock, par value $0.0001 per share (the "Common Stock"), on the date of the closing of the Registrant's acquisition of GEDi Cube Intl Ltd. There were no other changes to the terms of the options.
One-third of the option vested on October 18, 2023. The remainder of the option vests equally on October 18, 2024 and October 18, 2025.
/s/ Francois Binette
2024-02-16